1,388
Views
92
CrossRef citations to date
0
Altmetric
Disease of the Year

Epidemiology of Behçet Disease

, MD, , MD, PhD, , MD, MBA, , MD & , MD, PhD
Pages 324-335 | Received 07 May 2012, Accepted 17 Aug 2012, Published online: 03 Oct 2012

REFERENCES

  • Adams F. The genuine works of Hippokrates. Translated from Greek. A preliminary discourse and annotations. 1849, Vol 1 Epidemics III, p. 403.
  • Feigenbaum A. Description of Behçet’s syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol. 1956;40:355–357.
  • Monacelli M, Nazzaro P. Behçet’s Disease. Basel: Karger; 1966.
  • Evereklioglu C. The migration pattern, patient selection with diagnostic methodological flaw and confusing naming dilemma in Behçet disease. Eur J Echocardiography. 2007;8:167–173.
  • Zouboulis ChC, Keitel W. A historical review of early descriptions of Adamantiades-Behçet’s disease. J Invest Dermatol. 2002;119:201–205.
  • Adamantiades B. Sur uncasd’iritis à hypopionrécidivant. Ann Ocul (Paris). 1931;168: 271–278.
  • Adamantiades B. Lathrombophlèbitecommequatriéme symptom de l’iritsrécidivante à hypopyon. Ann Ocul. 1946;179:143–148.
  • Adamantiades B. ACase of Relapsing Iritis with Hypopion (Greek). Athens: Archia Iatrikis Etairias; 1930:586–593.
  • Behçet H. Uber rezidivierende, apthose, durch ein virus verursachte geschwure in mund, am auge und an den genitalien. Dermatol Wochenschr. 1937;105:1152–1157.
  • Behçet H. Kurze mitteilunguberfokalsepsis mit aphthosenerscheinungen an mund, genitalien und veranderungen an den augen, als wahrscheinliche folge einer durch virus bedingten allgemeininfektion. Dermatol Wochenschr. 1938;107:1037–1040.
  • Behçet H. A propos d’uneentité morbid due probablement à un virus special donnant lieu à une affection généralisée se manifestant par pousséesrécidivant en trois regions principales et occasionnant en particulier des iritisrépétés. Bull Soc Fr Dermatol Syph. 1939;46:674–687.
  • Behçet H. Einige bemerkungen zu meinen beobachtungenuber den tri-symptomenkomplex. Med Welt. 1939;13:1222–1227.
  • Behçet H. Some observations on the clinical picture of the so-called triple symptoms complex. Dermatologica. 1940;81:73–83.
  • Jensen T. Sur les ulcerations aphteuses del la muqueuse de la bouche et del la peaugénitale combine avec les symptomesoculaires (=Syndrome Behçet). Acta Dermatol Venereol (Stockh). 1941;22:64–79.
  • Jensen T. Ulcerous haemorrhagic colitis associated with Behçet’s disease. Ugeskrift För Laeger. 1941;106:176–180.
  • International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–1080.
  • Ohno S, Ohguchi M, Hirose S, et al. Close association of HLABw51 with Behçet’s disease. Arch Ophthalmol. 1982;100:1455–1458.
  • Hirohata T, Kuratsune M, Nomura A, et al. Prevalence of Behcet’s syndrome in Hawaii:with particular reference to the comparison of the Japanese in Hawaii and Japan. Hawaii Med J. 1975;34:244–246.
  • Zouboulis CC, Kotter I, Djawari D, et al. Epidemiological features of Adamantiades-Behçet’s disease in Germany and Europe. Yonsei Med J. 1997;38:411–422.
  • Azizerli G, Kose AA, Sarica R, et al. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol. 2003;42:803–806.
  • Davatchi F, Shahram F, Chams-Davatchi C, et al. Behçet’s disease: from East to West. Clin Rheumatol. 2010;29:823–833.
  • Mahr A, Belarbi L, Wechsler B, et al. Population-based prevalence study of Behçet’s disease. Arthritis Rheum. 2008;58:3951–3959.
  • Nakae K, Masaki F, Hashimoto T, et al. Recent epidemiological features of Behçet’s disease in Japan. In: Godeau P, Wechsler B, eds. Behçet’s Disease. New York: Elsevier; 1993: 145–151.
  • Pivetti-Pezzi P. Behçet’sdisease in 1988. In: Ferraz de Oliveira LN, ed. Ophthalmology Today. New York: Elsevier; 1988: 81–83.
  • Salvarani C, Pipitone N, Catanoso MG, et al. Epidemiology and clinical course of Behçet’s disease in the Reggio Emilia Area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum. 2007;57:171–178.
  • Calamia KT, Wilson FC, Icen M, et al. Epidemiology and clinical characteristics of Behçet’s disease in the US: a population-based study. Arthritis Rheum. 2009;61:600–604.
  • Tugal-Tutkun I. Behçet’s uveitis. Middle East Afr J Ophthalmol. 2009;16:219–224.
  • Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50:297–350.
  • Tüzün Y, Yurdakul S, Mat MC, et al. Epidemiology of Behçet’s syndrome in Turkey. Int J Dermatol. 1996;35:618–620.
  • Zhang Z, Peng J, Hou X, et al. Clinical manifestations of Behcet’s disease in Chinese patients. APLAR J Rheumatol. 2006;9:244–247.
  • Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behçet’s disease in 661 cases: a multicenter study. Br J Dermatol.2007;157:901–906.
  • Cheng YK, Thong BY, Chng HH. Behcet’s disease: experience in a tertiary rheumatology centre in Singapore and a review of the literature. Ann Acad Med Singapore. 2004;33:510–514.
  • Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. Int J Dermatol. 2003;42:346–351.
  • Yazici H, Fresko I, Yurdakul S. Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol. 2007;3:148–155.
  • Yang P, Fang W, Meng Q, et al. Clinical features of Chinese patients with Behçet’s disease. Ophthalmology. 2008;115:312–318.
  • Sachdev N, Kapali N, Singh R, et al. Spectrum of Behçet’s disease in the Indian population. Int Ophthalmol. 2009;29:495–501.
  • Zafirakis P, Foster CS. Adamantiades-Behcet disease. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders; 2002: 632–652.
  • Tugal-Tutkun I, Urgancioglu M. Childhood-onset uveitis in Behcet disease: a descriptive study of 36 cases. Am J Ophthalmol. 2003;136:1114–1119.
  • Krause I, Uziel Y, Guedj D, et al. Childhood Behcet’ s disease: clinical features and comparison with adult-onset disease. Rheumatology (Oxford). 1999; 38:457–462.
  • Atmaca L, Boyvat A, Yalçındağ FN, et al. Behçet disease in children. Ocul Immunol Inflamm. 2011;19:103–107.
  • Tugal-TutkunI. Behçet disease in the developing world. Int Ophthalmol Clin. 2010;50:87–98.
  • London NJ, Rathinam SR, Cunningham ET Jr. The epidemiology of uveitis in developing countries. Int Ophthalmol Clin. 2010;50:1–17.
  • Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008;15:285–293.
  • Sengun A, Karadag R, Karakurt A, et al. Causes of uveitis in a referral hospital in Ankara, Turkey. Ocul Immunol Inflamm. 2005;13:45–50.
  • Ozdal PC, Sen E, Yazici A, et al. Patterns of childhood-onset uveitis in a referral center in Turkey. J Ophthalmic Inflamm Infect. 2012;2:13–19.
  • Kadayifçilar, S Eldem B, Tumer B. Uveitis in childhood. J Pediatr Ophthalmol Strabismus. 2003;40:335–340.
  • Soylu M, Ozdemir G, Anli A. Pediatric uveitis in southern Turkey. Ocul Immunol Inflamm.1997;5:197–202.
  • BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol. 2005;89:444–448.
  • Friling R, Kramer M, Snir M, et al. Clinical course and outcome of uveitis in children. J AAPOS. 2005;9:379–382.
  • Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30:943–948.
  • Al-Mezaine HS, Kangave D, Abu El-Asrar AM. Patterns of uveitis in patients admitted to a University Hospital in Riyadh, Saudi Arabia. Ocul Immunol Inflamm. 2010;18:424–431.
  • Hamade IH, Elkum N, Tabbara KF. Causes of uveitis at a referral center in Saudi Arabia. Ocul Immunol Inflamm. 2009;17:11–16.
  • Islam SM, Tabbara KF. Causes of uveitis at The Eye Center in Saudi Arabia: a retrospective review. Ophthalmic Epidemiol. 2002;9:239–249.
  • Khairallah M, Ben Yahia S, Ladjimi A, et al. Pattern of uveitis in a referral center in Tunisia, North Africa. Eye (Lond). 2007;21:33–39.
  • Khairallah M, Attia S, Zaouali S, et al. Pattern of childhood onset uveitis in a referral center in Tunisia, North Africa. Ocul Immunol Inflamm. 2006;14:225–231.
  • Soheilian M, Heidari K, Yazdani S, et al. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004;12:297–310.
  • Llorenç Bellés V, Adán Civera A, Espinosa Garriga G, et al. Uveitis diagnosis characterization at a referral centre in the area of Barcelona. Med Clin (Barc). 2012;138:277–282.
  • Keino H, Nakashima C, Watanabe T, et al. Frequency and clinical features of intraocular inflammation in Tokyo. Clin Exp Ophthalmol. 2009;37:595–601.
  • Wakabayashi T, Morimura Y, Miyamoto Y, et al. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm.2003;11:277–286.
  • Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41–44.
  • Kotake S, Furudate N, Sasamoto Y, et al. Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol. 1996;234:599–603.
  • Cimino L, Aldigeri R, Salvarani C, et al. The causes of uveitisin areferral centre of Northern Italy. Int Ophthalmol. 2010;30:521–529.
  • Pivetti-Pezzi P, Accorinti M, La Cava M, et al. Endogenousuveitis: an analysis of 1417 cases. Ophthalmologica. 1996;210:234–238.
  • Paroli MP, Spinucci G, Liverani M, et al. Uveitis in childhood: an Italianclinical and epidemiological study. Ocul Immunol Inflamm. 2009;17:238–242.
  • Pathanapitoon K, Kunavisarut P, Ausayakhun S, et al. Uveitisin atertiaryophthalmology centre in Thailand. Br J Ophthalmol. 2008;92:474–478.
  • Oruc S, Kaplan AD, Galen M, et al. Uveitis referral pattern in a Midwest University Eye Center. Ocul Immunol Inflamm. 2003;11:287–298.
  • Bodaghi B, Cassoux N, Wechsler B, et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore). 2001;80:263–270.
  • Merrill PT, Kim J, Cox TA, et al. Uveitis in the southeastern United States. Curr Eye Res. 1997;16:865–874.
  • Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114:593–599.
  • McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. UCLA Community-based Uveitis Study Group. Am J Ophthalmol. 1996;121:35–46.
  • Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116:1544–1551.
  • Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111:2299–2306.
  • Kump LI, Cervantes-Castaneda R, Androudi SN, et al. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005;112:1287–1292.
  • Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a German interdisciplinary uveitis center: analysis of 1916 patients. J Rheumatol. 2009;36:127–136.
  • Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol. 2004;52:121–125.
  • Biswas J, Narain S, Das D, et al. Pattern of uveitis in a referral uveitis clinic in India. Int Ophthalmol. 1996;20:223–228.
  • Das D, Biswas J, Ganesh SK. Pattern of uveitis in a referral uveitis clinic in India. Indian J Ophthalmol. 1995;43:117–121.
  • Das D, Bhattacharjee H, Bhattacharyya PK, et al. Pattern of uveitis in North East India: a tertiaryeye care center study. Indian J Ophthalmol. 2009;57:144–146.
  • Tran VT, Auer C, Guex-Crosier Y, et al. Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol. 1994;18:293–298.
  • Stoffel PB, Sauvain MJ, von Vigier RO, et al. Non-infectious causes of uveitis in 70 Swiss children. Acta Paediatr. 2000;89:955–958.
  • Smit RL, Baarsma GS, De Vries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol. 1993;17:71–76.
  • Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol.1992;76:137–141.
  • de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87:879–884.
  • de-la-Torre A, López-Castillo CA, Rueda JC, Mantilla RD, et al. Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia. Clin Exp Ophthalmol. 2009;37:458–466.
  • Päivönsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand. 2000;78:84–88.
  • Bella-Hiag A, Mvogo CE, Ellong A. Uveitis: epidemiological aspects at the Hospital Laquintinie de Douala. Ophthalmologica. 2001;215:30–33.
  • Kaimbo Wa Kimbo D, Bifuko A, Dernouchamps JP, et al. Chronic uveitis in Kinshasa (DR Congo). Bull Soc Belge Ophtalmol. 1998;270:95–100.
  • Ronday MJ, Stilma JS, Barbe RF, et al. Blindness from uveitis in a hospital population in Sierra Leone. Br J Ophthalmol. 1994;78:690–693.
  • Yoshida A, Kawashima H, Motoyama Y, et al. Comparison of patients with Behçet’s disease in the 1980s and 1990s. Ophthalmology.2004;111:810–815.
  • Akiyama K, Numaga J, Yoshida A, et al. Statistical analysis of endogenous uveitis at Tokyo University Hospital. Jpn J Ophthalmol. 2006;50:69–71.
  • Kitamei H, Kitaichi N, Namba K, et al. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol. 2009;87:424–428.
  • Kotake S, Furudate N, Sasamoto Y, et al. Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol. 1997;235:5–9.
  • Ando K, Fujino Y, Hijikata K, et al. Epidemiological features and visual prognosis of Behçet’s disease. Jpn J Ophthalmol. 1999;43:312–317.
  • Mishima S, Masuda K, Izawa Y, et al. The eighth Frederick H Verhoeff lecture. Behçet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc.1979;77:225–279.
  • Shahram F, Davatchi F, Nadji AN, et al. Recent epidemiological data on Behçet’s disease in Iran. The 2001 Survey. In: Zouboulis CC, ed. Adamantiades-Behcet’s Disease. New York: Kluwer/Plenum; 2003:31–36.
  • Kitaichi N, Miyazaki A, Stanford MR, et al. Ocular features of Behçet’s disease: an international collaborative study. Br J Ophthalmol. 2007;91:1579–1782.
  • Pivetti-Pezzi P, Accorinti M, Abdulaziz MA et al. Behçet’sdisease in children. Jpn J Ophthalmol. 1995;39:309–314.
  • Sarica R, Azizerli G, Kose A et al. Juvenile Behçet’s disease among 1784 Turkish Behçet’s patients. Int J Dermatol. 1996;35:109–111.
  • Treudler R, Orfanos CE, Zouboulis CC. Twenty-eight cases of juvenile-onset Adamantiades-Behçet disease in Germany. Dermatology. 1999;199:15–19.
  • Kitaichi N, Miyazaki A, Stanford MR, et al. Low prevalence of juvenile-onset Behçet’s disease with uveitis in East/South Asian people. Br J Ophthalmol. 2009;93:1428–1430.
  • Citirik M, Berker N, Songur MS, et al. Ocular findings in childhood-onset Behçet disease. J AAPOS. 2009;13:391–395.
  • Hazirolan D, Sungur G, Duman S. Demographic, Clinical, and ocular features in patients with late-onset Behçet disease. Ocul Immunol Inflamm. 2012;20:119–124.
  • Tsai J, Chen GS, Lu LW, et al. Late-onset Behçet’s disease does not correlate with indolent clinical course: report of seven Taiwanese patients. J Eur Acad Dermatol Venereol. 2008;22:596–600.
  • Saricaoglu H, Karadogan SK, Bayazit N. Clinical features of late-onset Behçet’s disease: report of nine cases. Int J Dermatol. 2006;45:1284–1287.
  • Sungur G, Hazirolan D, Hekimoglu E, et al. Late-onset Behçet’s disease: demographic, clinical, and ocular features. Graefes Arch Clin Exp Ophthalmol. 2010;248:1325–1330.
  • Citirik M, Berker N, Songur MS, et al. Ocular manifestations of late-onset Behçet disease. Ophthalmologica. 2011;225:21–26.
  • Sungur GK, Hazirolan D, Yalvac I, et al. Clinical and demographic evaluation of Behçet disease among different paediatric age groups. Br J Ophthalmol. 2009;93:83–87.
  • Kone-PautI, Yurdakul S, Bahabri SA, et al. Clinical features of Behçet’s disease in children: an international collaborative study of 86 cases. J Pediatr. 1998;132:721–725.
  • Valesini G, Pivetti-Pezzi P, Catarinelli G, et al. Clinical manifestations of Behçet’s disease in Italy: study of 155 patients at Rome University. In: O’Duffy JD, Kokmen E, eds. Behçet’s Disease:Basic and Clinical Aspects. New York: Dekker; 1991: 279–289.
  • Neves FS, Caldas CA, Lage LV, et al. Far away from the silk route: demographic and clinical features of Behçet’s disease in 106 Brazilian patients. Clin Rheumatol. 2009;28:543–546.
  • Bang D, Lee JH, Lee ES, et al. Epidemiologic and clinical survey of Behçet’s disease in Korea: the first multicenter study. J Korean Med Sci. 2001;16:615–618.
  • Wang LY, Zhao DB, Gu J, et al. Clinical characteristics of Behçet’s disease in China. Rheumatol Int. 2010;30:1191–1196.
  • Ideguchi H, Suda A, Takeno M, et al. Behçet disease: evolution of clinical manifestations. Medicine. 2011;90:125–132.
  • Merrill PT, Kim J, Cox TA, et al. Uveitis in the southeastern United States. Curr Eye Res. 1997;16:865–874.
  • Davatchi F, Shahram F, Shams H, et al. Gender influence on ocular manifestations and their outcome in Behcet’sdisease: a long-term follow-up of up to 20 years. Clin Rheumatol. 2011;30:541–547.
  • Ohno S, Aoki K, Sugiura S, et al. HL-A5 and Behçet’s disease. Lancet. 1973;2:1383–1384.
  • Durrani K, Papaliodis GN. The genetics of Adamantiades-Behcet’s disease. Semin Ophthalmol. 2008;23:73–79.
  • Soylu M, Ersöz TR, Erken E. The association between HLA B5 and ocular involvement in Behçet’ disease in southern Turkey. Acta Ophthalmol (Copenh). 1992;70:786–789.
  • Gül A, Uyar FA, Inanc M, et al. Lack of association of HLA-B*51 with a severe disease course in Behçet’s disease. Rheumatology (Oxford). 2001;40:668–672.
  • Kaburaki T, Takamoto M, Numaga J, et al. Genetic association of HLA-A*2601 with ocular Behçet’s disease in Japanese patients. Clin Exp Rheumatol. 2010;28(4 suppl 60):S39–S44.
  • Davatchi F, Shahram F, Chams-Davatchi C, et al. Behçet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis. 2012;13:367–373.
  • Deuter CME, Kotter I, Wallace GR, et al. Behçet’s disease: ocular effects and treatment. Prog Ret Eye Res. 2008;27:111–136.
  • Akman-Demir G, Serdaroglu P, Tasci B. Clinical pattern of neurologic involvement on Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain. 1999;122:2171–2182.
  • Gualdi GF, Pivetti-Pezzi P, Accorinti M, et al. Magnetic resonance imaging in Behçet’s disease patients. In: Godeau P, Wechlser B, eds. Behçet’s Disease. New York: Elsevier; 1993: 451–456.
  • Parisi L, Terracciano ME, Valente GO, et al. Pre-symtomatic neurological involvement in Behçet’s disease: the diagnostic role of magnetic transcranial stimulation. Electroencheph Clin Neurophysiol. 1996;101:42–47.
  • Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behçet’s disease: an update. Curr Opin Rheumatol. 2011;23:24–31.
  • Al-Dalaan AN, al-Balaa SR, Ramahi K, et al. Behçet’sdisease in Saudi Arabia. J Rheumatol. 1994;21:658–661.
  • Morelli S, Perrone C, Ferrante L, et al. Cardiac involvement in Behçet’s disease. Cardiology. 1997;88:513–517.
  • Shahram F, Eslami M, Shakoori B et al. Cardiac involvement in Behçet’s disease: a case control study. In: Bang D, Lee E, Lee S, eds. Behçet’s Disease. Seoul, Korea: Design Mecca; 2001: 791–799.
  • Gürgün C, Ercan E, Ceyhan C, et al. Cardiovascular involvement in Behçet’s disease. Jpn Heart J. 2002;43:389–398.
  • Zamir E, Bodaghi B, Tugal-Tutkun I, et al. Conjunctival ulcers in Behçet’s disease. Ophthalmology. 2003;110:1137–1141.
  • Tarzi MD, Lightman S, Longhurst HJ. An exacerbation of Behçet’s syndrome presenting with bilateral papillitis. Rheumatology. 2005;44:953–954.
  • Lew H, Lee JB, Han SH, et al. Neuro-Behçet’s disease presenting with isolated unilateral lateral rectus muscle palsy. Yonsei Med J. 1999;40:294–296.
  • Hammami S, Ben Yahia S, Mahjoub S, et al. Orbital inflammation associated with Behçet’s disease. Clin Exp Ophthalmol. 2006;34:188–190.
  • Shenoy R. Conjunctival ulcer: mucocutaneous or ocular manifestation of Behçet’s disease? A case report. Eur J Ophthalmol. 2002;12:435–436.
  • Tugal-Tutkun I, Onal S, Yaycioglu AR, et al. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138:373–380.
  • Khairallah M, Attia S, Ben Yahia S, et al. Pattern of uveitis in Behçet’s disease in a referral center in Tunisia, North Africa. Int Ophthalmol. 2009;29:135–141.
  • Saleh OA, Birnbaum AD, Tessler HH, et al. Behçet uveitis in the American Midwest. Ocul Immunol Inflamm. 2012;20:12–17.
  • Taylor SR, Singh J, Menezo V, et al. Behçet disease: visual prognosis and factors influencing the development of visual loss. Am J Ophthalmol. 2011;152:1059–1066.
  • BenEzra D, Cohen E. Treatment and visual prognosis in Behçet’s disease. Br J Ophthalmol. 1986;70:589–592.
  • Wakefield D, Cunningham ET Jr, Tugal-Tutkun I, et al. Controversies in Behçet disease. Ocul Immunol Inflamm. 2012;20:6–11.
  • Barra C, Belfort Júnior R, Abreu MT, et al. Behçet’s disease in Brazil: a review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol. 1991;35:339–346.
  • Chung YM, Liu JH, Tsi ST. Behçet’s disease in Taiwan: a review of 53 cases. Jpn J Ophthalmol. 1986;30:318–323.
  • Chung YM, Lin YC, Tsai CC, et al. Behçet’s disease with uveitis in Taiwan. J Chin Med Assoc. 2008;71:509–516.
  • Pivetti-Pezzi P, Accorinti M, La Cava M, et al. Ocular features of Behçet’s disease in Italy. In: Godeau P, Wechlser B, eds. Behçet’s Disease. New York: Elsevier; 1993: 615–618.
  • Ambresin A, Tran T, Spertini F, et al. Behçet’s disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm. 2002;10:53–63.
  • Sakamoto M, Akazawa K, Nishioka Y, et al. Prognosis factors of vision in patients with Behçet disease. Ophthalmology. 1995;102:317–321.
  • Bonfioli AA, Orefice F. Behçet’s disease. Semin Ophthalmol. 2005;20:199–206.
  • Tugal-Tutkun I. Behçet’s disease. In: Gupta A, Gupta V, Herbort CP, Khairallah M, eds. Uveitis Text and Imaging. New Delhi: Jaypee Brothers; 2009:397–413.
  • Elgin U, Berker N, Batman A. Incidence of secondary glaucoma in Behçet disease. J Glaucoma. 2004;13:441–444.
  • Kahloun R, Ben Yahia S, Mbarek S, et al. Macular involvement in patients with Behçet’s uveitis. J Ophthalmic Inflamm Infect. 2012 May 2. [Epub ahead of print]
  • Ben Yahia S, Kahloun R, Jelliti B, et al. Branch retinal artery occlusion associated with Behçet disease. Ocul Immunol Inflamm. 2011;19:293–295.
  • Al-Dhibi H, Abouammoh M, Al-Harthi E, et al. Macular hole in Behçet’s disease. Indian J Ophthalmol. 2011;59:359–362.
  • Kaçmaz RO, Kempen JH, Newcomb C, et al. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146:828–836.
  • Yazici H, Tüzün Y, Pazarli H, et al. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis. 1984;43:783.
  • Demiroglu H, Barista I, Dundar S. Risk factor assessment and prognosis of eye involvement in Behçet’s disease in Turkey. Ophthalmology. 1997;104:701–705.
  • Yu HG, Kim MJ, Sewoong F. Fluorescein angiography and visual acuity in active uveitis with Behçet disease. Ocul Immunol Inflamm. 2009;17:41–46.
  • Takeuchi M, Hokama H, Tsukahara R, et al. Risk and prognostic factors of poor visual outcome in Behcet’s disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol. 2005;243:1147–1152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.